You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NKTR-214

Showing 1 - 25 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARCOMA Trial in New York, Houston (NKTR-214, Nivolumab)

Active, not recruiting
  • SARCOMA
  • New York, New York
  • +1 more
May 6, 2022

Head Neck Cancer Trial in Madison (NKTR-214, anti-PD-1 therapy, Palliative Radiation)

Active, not recruiting
  • Head and Neck Cancer
  • NKTR-214
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
May 9, 2022

Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)

Completed
  • Covid-19
  • Coronavirus Disease 2019
  • Hialeah, Florida
  • +3 more
Mar 31, 2022

Advanced Cancer Trial in Chuo-ku (NKTR-214, Nivolumab)

Completed
  • Advanced Cancer
  • NKTR-214
  • Nivolumab
  • Chuo-ku, Tokyo, Japan
    Local Institution
Oct 1, 2021

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Solid Tumor Trial in New Haven, Portland, Houston (NKTR-214)

Completed
Has Results
  • Unspecified Adult Solid Tumor, Protocol Specific
  • NKTR-214
  • New Haven, Connecticut
  • +2 more
Jul 9, 2021

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

Withdrawn
  • Metastatic Melanoma
  • Bempegaldesleukin (NKTR-214)
  • +2 more
  • Duarte, California
  • +2 more
Jun 28, 2021

Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)

Completed
  • Urinary Bladder Neoplasm
  • Neoplasm Metastasis
  • Bempegaldesleukin
  • Nivolumab
  • San Francisco, California
  • +69 more
Jul 22, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • NKTR-214 (Cohort A)
  • +6 more
  • Los Angeles, California
  • +5 more
Nov 10, 2022

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Bempegaldesleukin, Radical

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Nivolumab
  • +2 more
  • Gilbert, Arizona
  • +115 more
Jan 9, 2023

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Omaha, Nebraska
  • +3 more
Dec 16, 2022

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, NKTR-214)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +5 more
Jul 10, 2019

Low Back Pain, Chronic Pain Trial in United States (NKTR-181 BID tablets)

Completed
Has Results
  • Low Back Pain
  • Chronic Pain
  • NKTR-181 BID tablets
  • Saraland, Alabama
  • +55 more
Jun 15, 2021

Healthy Trial in Dallas (LY3471851, Placebo, Levocetirizine)

Recruiting
  • Healthy
  • Dallas, Texas
    Covance Dallas
Oct 18, 2022

Gastroenteritis Trial in Japan (Placebo, HIL-214)

Recruiting
  • Gastroenteritis
  • Placebo
  • HIL-214
  • Fukui-Shi, Japan
  • +3 more
Aug 18, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
Mar 18, 2022

Gastroenteritis Trial (HIL-214, Placebo)

Not yet recruiting
  • Gastroenteritis
  • HIL-214
  • Placebo
  • (no location specified)
Apr 26, 2023

GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers

Completed
  • Periodontitis, Adult
  • miRNA-223 & -214 detection
  • Fayoum, Egypt
    faculty of dentistry, Fayoum university
Sep 26, 2023

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022